- In the United States, neither cromolyn nor nedocromil is available in HFA- containing (MDIs), and no formulation of nedocromil is currently marketed for asthma.
- King Pharmaceuticals also announced the discontinuation of Intal solution for nebulizer treatments also
- Mast cell stabilizers are no longer an alternative treatment in asthma in the United States
| | | |